A protein associated with youth appears to help keep the brain's immune cells doing their job. Researchers at The Icahn School of Medicine at Mount Sinai report in Nature Communications, in a study published August 12, that removing TIMP2 pushed microglia toward several features seen in aging and neurodegeneration. Going the other direction, restoring TIMP2 in the blood of aged mice improved how well microglia cleared cellular debris and lowered molecular markers tied to inflammation and other maladaptive states.
Microglia are the brain's resident immune cells, responsible for clearing debris, supporting neural circuits, and responding to injury. As animals age, those cells become less efficient and can settle into states that promote inflammation and impaired brain function. That drift is one of the reasons aging remains the single strongest risk factor for Alzheimer's disease and other neurodegenerative disorders, even though the underlying biology has never been fully mapped.
What makes the result notable is the direction of the effect. Rather than simply cataloguing what goes wrong in old microglia, the Mount Sinai team showed that a circulating factor delivered through the blood could shift aged cells back toward a more functional profile. That points to the possibility that at least some age-related decline in brain immune function is not fixed, and that factors carried in blood may be part of what maintains it.
This is mouse work, and it establishes a biological role for TIMP2 rather than a treatment. Its value for now is as a lead: a specific, measurable protein tied to microglial health that researchers can pursue in asking why the aging brain becomes vulnerable to disease in the first place.